| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Unc-13 | 1.18e-04 | 3 | 118 | 2 | IPR027080 | |
| Domain | - | 2.36e-04 | 4 | 118 | 2 | 3.90.1460.10 | |
| Domain | MAP7 | 2.36e-04 | 4 | 118 | 2 | PF05672 | |
| Domain | GTF2I | 2.36e-04 | 4 | 118 | 2 | PS51139 | |
| Domain | GTF2I | 2.36e-04 | 4 | 118 | 2 | PF02946 | |
| Domain | MAP7_fam | 2.36e-04 | 4 | 118 | 2 | IPR008604 | |
| Domain | GTF2I | 2.36e-04 | 4 | 118 | 2 | IPR004212 | |
| Domain | Munc13_dom-2 | 3.91e-04 | 5 | 118 | 2 | IPR014772 | |
| Domain | MHD2 | 3.91e-04 | 5 | 118 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 3.91e-04 | 5 | 118 | 2 | IPR019558 | |
| Domain | Membr_traf_MHD | 3.91e-04 | 5 | 118 | 2 | PF10540 | |
| Domain | DUF1041 | 3.91e-04 | 5 | 118 | 2 | SM01145 | |
| Domain | PAK_BD | 5.84e-04 | 6 | 118 | 2 | IPR033923 | |
| Domain | AT_hook | 6.44e-04 | 27 | 118 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 6.44e-04 | 27 | 118 | 3 | IPR017956 | |
| Domain | Munc13_1 | 8.14e-04 | 7 | 118 | 2 | IPR014770 | |
| Domain | MHD1 | 8.14e-04 | 7 | 118 | 2 | PS51258 | |
| Domain | DUF1041 | 8.14e-04 | 7 | 118 | 2 | PF06292 | |
| Domain | CAPS_dom | 8.14e-04 | 7 | 118 | 2 | IPR010439 | |
| Domain | UBA | 8.81e-04 | 30 | 118 | 3 | SM00165 | |
| Domain | UBA | 1.51e-03 | 36 | 118 | 3 | PF00627 | |
| Domain | UBIQUITIN_1 | 1.63e-03 | 37 | 118 | 3 | PS00299 | |
| Domain | - | 1.72e-03 | 10 | 118 | 2 | 4.10.1060.10 | |
| Domain | STI1 | 1.72e-03 | 10 | 118 | 2 | SM00727 | |
| Domain | STI1_HS-bd | 1.72e-03 | 10 | 118 | 2 | IPR006636 | |
| Domain | S_TKc | 2.02e-03 | 359 | 118 | 8 | SM00220 | |
| Domain | - | 2.51e-03 | 12 | 118 | 2 | 3.90.810.10 | |
| Domain | UBA | 2.70e-03 | 44 | 118 | 3 | IPR015940 | |
| Domain | Pkinase | 2.91e-03 | 381 | 118 | 8 | PF00069 | |
| Domain | UBA | 3.26e-03 | 47 | 118 | 3 | PS50030 | |
| Domain | PH | 3.35e-03 | 229 | 118 | 6 | PF00169 | |
| Domain | - | 3.40e-03 | 391 | 118 | 8 | 2.30.29.30 | |
| Domain | PBD | 4.48e-03 | 16 | 118 | 2 | SM00285 | |
| Domain | UBIQUITIN_2 | 4.82e-03 | 54 | 118 | 3 | PS50053 | |
| Domain | PBD | 5.06e-03 | 17 | 118 | 2 | PF00786 | |
| Domain | - | 5.61e-03 | 57 | 118 | 3 | 3.30.50.10 | |
| Domain | C1_1 | 5.61e-03 | 57 | 118 | 3 | PF00130 | |
| Domain | PH_dom-like | 5.67e-03 | 426 | 118 | 8 | IPR011993 | |
| Domain | Znf_NHR/GATA | 5.89e-03 | 58 | 118 | 3 | IPR013088 | |
| Domain | Ubiquitin_dom | 5.89e-03 | 58 | 118 | 3 | IPR000626 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ELOB CHERP MAP1B MAP6 RBM10 ZKSCAN8 DIDO1 APLP2 BRD3 SEC31A AHDC1 PPP1R10 LLGL1 PIN4 PAK1IP1 CDC5L DEK TNXB UNC13A | 9.06e-09 | 1082 | 123 | 19 | 38697112 |
| Pubmed | ELOB KMT2B PCNX3 DIDO1 APLP2 BRD3 MAP7 BCOR AHDC1 CASZ1 PRR12 PPP1R10 MAP7D1 SEPTIN3 ANLN CDK13 NUMB PAK1IP1 NMT1 PRRC2A CEP170B EDRF1 | 1.35e-08 | 1497 | 123 | 22 | 31527615 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B RBM10 PARG DIDO1 BRD3 BCOR ANLN CDK13 CHTF18 YY1AP1 RERE PAK1IP1 NMT1 PRRC2A CCDC9 CLUH | 1.61e-08 | 774 | 123 | 16 | 15302935 |
| Pubmed | KMT2B RBM10 HSPBP1 BCOR AHDC1 MAP7D1 CLEC4F KIAA1549L RORA YY1AP1 RERE PRRC2A TP53 RAD23A | 3.61e-08 | 608 | 123 | 14 | 16713569 | |
| Pubmed | KMT2B MAP1B RBM10 BEND3 DIDO1 BCOR PPP1R10 ANLN PAK2 NUMB CDC5L PRRC2A TP53 | 8.29e-08 | 549 | 123 | 13 | 38280479 | |
| Pubmed | CHERP MAP1B RBM10 SEC31A BCOR PIN4 PAK2 CDC5L DEK PRRC2A TP53 | 1.93e-07 | 399 | 123 | 11 | 35987950 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ELOB CHERP MAP1B RBM10 PARG DIDO1 BCOR PPP1R10 PTPN12 PDLIM3 PAK2 NUMB CDC5L NMT1 PRRC2A TP53 | 2.09e-07 | 934 | 123 | 16 | 33916271 |
| Pubmed | UNC13B ATG13 RBM10 BEND3 MAP3K4 MAP7D1 CACNA1H YY1AP1 RERE CLEC16A CEP170B | 2.35e-07 | 407 | 123 | 11 | 12693553 | |
| Pubmed | ELOB KMT2B RBM10 BEND3 DIDO1 BCOR AHDC1 PRR12 MAP7D1 ANLN CDK13 PIN4 PAK2 DEK PRRC2A TP53 RAD23A | 3.72e-07 | 1103 | 123 | 17 | 34189442 | |
| Pubmed | MAP1B PARG DIDO1 CC2D1B PRR12 MAP7D1 ARAP3 LLGL1 CDK13 CHTF18 YY1AP1 NMT1 CLEC16A | 5.65e-07 | 650 | 123 | 13 | 38777146 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ELOB CHERP KMT2B RBM10 ZKSCAN8 BEND3 DIDO1 BRD3 MAP7 BCOR AHDC1 CASZ1 PRR12 PPP1R10 MAP7D1 CDK13 CDC5L DEK | 7.23e-07 | 1294 | 123 | 18 | 30804502 |
| Pubmed | ELOB BEND3 BRD3 AHDC1 PPP1R10 PTPN12 CDK13 RTL9 CDC5L DEK CCDC9 | 9.48e-07 | 469 | 123 | 11 | 27634302 | |
| Pubmed | RBM10 BACH2 ESRRG ZKSCAN8 DIDO1 BRD3 ZNF710 PPP1R10 PKNOX1 RORA CDC5L DEK TP53 NOBOX | 1.11e-06 | 808 | 123 | 14 | 20412781 | |
| Pubmed | DIDO1 MAP7 PRKD3 PPP1R10 PTPN12 ANLN CDK13 PAK2 NUMB NMT1 PRRC2A | 1.87e-06 | 503 | 123 | 11 | 16964243 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAP1B ATG13 MAP7 PRAG1 VPS13D MAP7D1 ANLN NUMB GNAS CEP170B EDRF1 TP53 TNS3 MTSS2 | 2.33e-06 | 861 | 123 | 14 | 36931259 |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ZKSCAN8 DIDO1 BRD3 SEC31A MAP7 GTF2IRD2B MAP7D1 MZF1 CDK13 CHTF18 NUMB DEK CLEC16A PRRC2A | 5.30e-06 | 925 | 123 | 14 | 28986522 |
| Pubmed | 5.37e-06 | 268 | 123 | 8 | 33640491 | ||
| Pubmed | TMEM52 CHERP PCNX3 BACH2 OBSCN PIDD1 DIDO1 CC2D1B AHDC1 SH3D21 GTF2IRD2B PTPN12 PKNOX1 GNAS DEK CEP170B | 6.32e-06 | 1215 | 123 | 16 | 15146197 | |
| Pubmed | MAP6 DIDO1 SEC31A BCOR MAP7D1 SEPTIN3 PAK2 PAK3 CDC5L GOLGA8A PRRC2A UNC13A CEP170B MTSS2 | 8.36e-06 | 963 | 123 | 14 | 28671696 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | KMT2B ZKSCAN8 DIDO1 BRD3 BCOR CASZ1 PPP1R10 ANLN PIN4 DEK RAD23A | 1.12e-05 | 608 | 123 | 11 | 36089195 |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 12871971 | ||
| Pubmed | hHR23B is required for genotoxic-specific activation of p53 and apoptosis. | 1.24e-05 | 2 | 123 | 2 | 16924240 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 17437012 | ||
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | 1.24e-05 | 2 | 123 | 2 | 10440375 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 19403693 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 32947864 | ||
| Pubmed | A novel type of myosin encoded by the mouse deafness gene shaker-2. | 1.24e-05 | 2 | 123 | 2 | 9703981 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 29295976 | ||
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | 1.24e-05 | 2 | 123 | 2 | 11832228 | |
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | 1.24e-05 | 2 | 123 | 2 | 23229896 | |
| Pubmed | Replication Stress Response Modifies Sarcomeric Cardiomyopathy Remodeling. | 1.24e-05 | 2 | 123 | 2 | 34323119 | |
| Pubmed | Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions. | 1.24e-05 | 2 | 123 | 2 | 16894028 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 36563883 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 35613050 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 18701688 | ||
| Pubmed | Numb-dependent integration of pre-TCR and p53 function in T-cell precursor development. | 1.24e-05 | 2 | 123 | 2 | 25321479 | |
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 1.24e-05 | 2 | 123 | 2 | 15388857 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 11792326 | ||
| Pubmed | p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer. | 1.24e-05 | 2 | 123 | 2 | 15099969 | |
| Pubmed | Map7/7D1 and Dvl form a feedback loop that facilitates microtubule remodeling and Wnt5a signaling. | 1.24e-05 | 2 | 123 | 2 | 29880710 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 17561838 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 18656471 | ||
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | 1.24e-05 | 2 | 123 | 2 | 28489077 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 22509368 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 32501652 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 23980194 | ||
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | 1.24e-05 | 2 | 123 | 2 | 22066784 | |
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | 1.24e-05 | 2 | 123 | 2 | 32187536 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 22814762 | ||
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | 1.24e-05 | 2 | 123 | 2 | 28426965 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 23770256 | ||
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | 1.24e-05 | 2 | 123 | 2 | 31851910 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 12070347 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 30970177 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 23070049 | ||
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | 1.24e-05 | 2 | 123 | 2 | 28772123 | |
| Pubmed | Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site. | 1.24e-05 | 2 | 123 | 2 | 25889998 | |
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | 1.24e-05 | 2 | 123 | 2 | 17267576 | |
| Pubmed | P53 Promotes Retinoid Acid-induced Smooth Muscle Cell Differentiation by Targeting Myocardin. | 1.24e-05 | 2 | 123 | 2 | 29482449 | |
| Pubmed | Numb Promotes Autophagy through p53 Pathway in Acute Kidney Injury Induced by Cisplatin. | 1.24e-05 | 2 | 123 | 2 | 35795076 | |
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | 1.24e-05 | 2 | 123 | 2 | 30816091 | |
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | 1.24e-05 | 2 | 123 | 2 | 19558619 | |
| Pubmed | Phospho-tyrosine dependent protein-protein interaction network. | 1.62e-05 | 410 | 123 | 9 | 25814554 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MAP1B ATG13 PRAG1 DARS2 MAP3K4 PRKD3 PTPN12 ANLN CDK13 PAK3 NUMB DEK TNS3 | 2.15e-05 | 910 | 123 | 13 | 36736316 |
| Pubmed | 3.59e-05 | 568 | 123 | 10 | 9110174 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 14761400 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 28381640 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 15182717 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 35821094 | ||
| Pubmed | cGAS surveillance of micronuclei links genome instability to innate immunity. | 3.71e-05 | 3 | 123 | 2 | 28738408 | |
| Pubmed | Involvement of the DNA repair protein hHR23 in p53 degradation. | 3.71e-05 | 3 | 123 | 2 | 14645509 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 33105896 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 31898732 | ||
| Pubmed | A role for caspase 2 and PIDD in the process of p53-mediated apoptosis. | 3.71e-05 | 3 | 123 | 2 | 18238895 | |
| Pubmed | Cooperation among Numb, MDM2 and p53 in the development and progression of pancreatic cancer. | 3.71e-05 | 3 | 123 | 2 | 23881403 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 23335286 | ||
| Pubmed | Multisite autophosphorylation of p21-activated protein kinase gamma-PAK as a function of activation. | 3.71e-05 | 3 | 123 | 2 | 10075701 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 23335370 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 23658173 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 18507705 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 15100712 | ||
| Pubmed | RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53. | 3.71e-05 | 3 | 123 | 2 | 31591476 | |
| Pubmed | Internal deletion of BCOR reveals a tumor suppressor function for BCOR in T lymphocyte malignancies. | 3.71e-05 | 3 | 123 | 2 | 28827447 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 27587435 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 18172499 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 15988013 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 20395368 | ||
| Pubmed | Prognostic significance of PAK family kinases in acute myeloid leukemia. | 3.71e-05 | 3 | 123 | 2 | 30890765 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 22595758 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 33810510 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 26174965 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 16982033 | ||
| Pubmed | Munc13- and SNAP25-dependent molecular bridges play a key role in synaptic vesicle priming. | 3.71e-05 | 3 | 123 | 2 | 37343100 | |
| Pubmed | Group I Paks as therapeutic targets in NF2-deficient meningioma. | 3.71e-05 | 3 | 123 | 2 | 25596744 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 8037842 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 26160192 | ||
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 23468968 | ||
| Pubmed | A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway. | 3.71e-05 | 3 | 123 | 2 | 15064742 | |
| Pubmed | 3.71e-05 | 3 | 123 | 2 | 17639022 | ||
| Pubmed | Mutant p53 leads to low-grade IFN-I-induced inflammation and impairs cGAS-STING signalling in mice. | 3.71e-05 | 3 | 123 | 2 | 37377275 | |
| Interaction | ZBTB7C interactions | 8.32e-06 | 22 | 121 | 4 | int:ZBTB7C | |
| Interaction | KIF2A interactions | 1.57e-05 | 242 | 121 | 9 | int:KIF2A | |
| Interaction | MECP2 interactions | ELOB CHERP MAP1B MAP6 RBM10 ZKSCAN8 DIDO1 APLP2 BRD3 SEC31A AHDC1 PPP1R10 LLGL1 ANLN PIN4 PAK1IP1 CDC5L DEK TNXB UNC13A TP53 | 2.51e-05 | 1287 | 121 | 21 | int:MECP2 |
| Interaction | DNAJC13 interactions | 2.52e-05 | 143 | 121 | 7 | int:DNAJC13 | |
| GeneFamily | UNC13 homologs | 1.01e-04 | 4 | 75 | 2 | 836 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | CHERP MAP1B MAP6 BACH2 NAP1L5 AHDC1 CASZ1 TBC1D24 KIAA1549L PKNOX1 PAK3 ZFHX2 GOLGA8A CNGB1 UNC13A | 8.05e-07 | 703 | 120 | 15 | M39070 |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 3.21e-05 | 194 | 120 | 7 | M7467 | |
| Coexpression | PEREZ_TP53_TARGETS | TMEM52 MAP6 CGAS OBSCN PIDD1 DIDO1 MAP7 BCOR AHDC1 LLGL1 PRRT3 RORA GNAS GOLGA8A CEP170B ARAP1 MTSS2 | 3.39e-05 | 1201 | 120 | 17 | M4391 |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP | 3.43e-05 | 196 | 120 | 7 | M4423 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP | 3.90e-05 | 200 | 120 | 7 | M5229 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.29e-08 | 193 | 122 | 8 | f27e2be497745098b5269aa799dd3d5f62d78ba7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.29e-08 | 193 | 122 | 8 | 4ccf984baebbb13ae916727137ce593fda7514a2 | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-07 | 187 | 122 | 7 | d9943e65eedab73d141eae524e2411653a751705 | |
| ToppCell | facs-Heart-LA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-07 | 187 | 122 | 7 | 7b13c3b67d66f3afb410141d5471c9e78a4d8623 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 8.88e-07 | 188 | 122 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 9.88e-07 | 191 | 122 | 7 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | T_cells-Central_memory_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.06e-06 | 193 | 122 | 7 | 725326d7e3604736b607c19f4069c81cb4f2d20c | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.13e-06 | 195 | 122 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.13e-06 | 195 | 122 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.30e-06 | 199 | 122 | 7 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.34e-06 | 200 | 122 | 7 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.77e-06 | 167 | 122 | 6 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.77e-06 | 167 | 122 | 6 | 91b14df450bfb6a2b406c88f8c75cd51eeb9e82b | |
| ToppCell | Ionocyte-iono-1|World / Class top | 7.25e-06 | 169 | 122 | 6 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.56e-06 | 174 | 122 | 6 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-06 | 176 | 122 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 179 | 122 | 6 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.11e-05 | 182 | 122 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.14e-05 | 183 | 122 | 6 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-05 | 185 | 122 | 6 | 3d6711030ca4328357b06d5497cf98cdefcd7f4f | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 185 | 122 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 185 | 122 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-05 | 186 | 122 | 6 | 15f2e5905486e33f6f7b3b3e9758a0559e8c61ee | |
| ToppCell | Cerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.29e-05 | 187 | 122 | 6 | 61b9d6eb131a674598aa8409d7fa909c8765442d | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.29e-05 | 187 | 122 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-05 | 188 | 122 | 6 | 340f0e3e65c7a00d82d26621ff37107458bebc41 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-05 | 188 | 122 | 6 | 9d384c0934f1461bc37b1f83e0877d7bee2116ee | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.37e-05 | 189 | 122 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.37e-05 | 189 | 122 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 189 | 122 | 6 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.37e-05 | 189 | 122 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-05 | 189 | 122 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.41e-05 | 190 | 122 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.41e-05 | 190 | 122 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-05 | 191 | 122 | 6 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-05 | 191 | 122 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.54e-05 | 193 | 122 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | facs-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 193 | 122 | 6 | 15c86e20b97b6983410b36d308cddff56d141c98 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.59e-05 | 194 | 122 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | frontal_cortex-Neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.68e-05 | 196 | 122 | 6 | de7d10da862f98894ce47244fbc992f4a12d63bb | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 196 | 122 | 6 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.78e-05 | 198 | 122 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.83e-05 | 199 | 122 | 6 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | proximal-mesenchymal-Airway_Smooth_Muscle-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.89e-05 | 200 | 122 | 6 | 6fa339666c4032b29ac521e88f0e917a57013cde | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 200 | 122 | 6 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | proximal-3-mesenchymal-Airway_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.89e-05 | 200 | 122 | 6 | e9a008bfe336002218c63d1c2231986e1b237621 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 200 | 122 | 6 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | proximal-mesenchymal-Airway_Smooth_Muscle|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.89e-05 | 200 | 122 | 6 | 5eeb8eb3fe74f5a8055c52ec77e38237bb63ed90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 200 | 122 | 6 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 2.01e-05 | 120 | 122 | 5 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.17e-05 | 122 | 122 | 5 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.95e-05 | 130 | 122 | 5 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.48e-05 | 148 | 122 | 5 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.82e-05 | 155 | 122 | 5 | a4f2fffa8d0de760c556c3f8f1c91804eedbfa68 | |
| ToppCell | lymphoid-T_cell-pro-T_cell|World / Lineage, cell class and subclass | 6.94e-05 | 80 | 122 | 4 | 9bd3ad5029eb84efcdbf08fe268c29fa9b0b302b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.46e-05 | 158 | 122 | 5 | 84c0a215dabf697ada036c2b9592d0c61b5077de | |
| ToppCell | Ciliated_cells-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 7.69e-05 | 159 | 122 | 5 | 0c65ae6140abd48c79b04758a6217709ddd15385 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.16e-05 | 165 | 122 | 5 | b1bbf5acdfc52bd8c7c7eb356d73b812eb6b908c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.16e-05 | 165 | 122 | 5 | 28f8297ec7b781149cc7ac2f5e441771083b8ee3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-05 | 166 | 122 | 5 | ec7bd549bda5f18aca8aebce5ba479a81abbbeda | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.42e-05 | 166 | 122 | 5 | 390cf5e56b72fcaf3b8520930bd35a3e3e173711 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.42e-05 | 166 | 122 | 5 | 9a341dc7b756252caeaac1e934384911c880a634 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.42e-05 | 166 | 122 | 5 | 8d5d09f25e8903d481c2097fed435e69d42ccdb5 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 9.96e-05 | 168 | 122 | 5 | 8697b40b2ec2cce68ef3beb4792eb3eff29be053 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-05 | 168 | 122 | 5 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.96e-05 | 168 | 122 | 5 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-05 | 168 | 122 | 5 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | Ionocyte|World / Class top | 1.05e-04 | 170 | 122 | 5 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-04 | 174 | 122 | 5 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-04 | 174 | 122 | 5 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 174 | 122 | 5 | 42dfb6f42b72e40e203b3ef341117bccf3553d54 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 174 | 122 | 5 | f04edf2ca6788875c9918611e416fb739924382e | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-04 | 175 | 122 | 5 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-04 | 175 | 122 | 5 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 177 | 122 | 5 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 177 | 122 | 5 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_TCM|URO / Disease, Lineage and Cell Type | 1.34e-04 | 179 | 122 | 5 | cdf972acf23c7a22c99a336ee0f9cc51e0fa6f67 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.34e-04 | 179 | 122 | 5 | 5be883d7d0be3180bb9844e4a757f0dd247294e4 | |
| ToppCell | facs-Heart-RA-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 180 | 122 | 5 | 174c643e046646e3b305dd7e5b120d2c9a46690f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-04 | 181 | 122 | 5 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.45e-04 | 182 | 122 | 5 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 183 | 122 | 5 | 7e2bac8b005155888ff4b41ef2e1d975dc17abc7 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-04 | 183 | 122 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 183 | 122 | 5 | 262387ee8d43b96e5f1a77c75124459a506a6172 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 183 | 122 | 5 | c85a707acbcb582912e8ac080a36d05f91cfd7a2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 184 | 122 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 184 | 122 | 5 | 3da93e7d8b62463e307cc0425c47dbd3bef66799 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 184 | 122 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 184 | 122 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.53e-04 | 184 | 122 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 184 | 122 | 5 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.56e-04 | 185 | 122 | 5 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.56e-04 | 185 | 122 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 185 | 122 | 5 | 11c147f3f5570c4761d2bcff3bad28146b4a5861 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.56e-04 | 185 | 122 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.56e-04 | 185 | 122 | 5 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 185 | 122 | 5 | a32d5cb596ebac80eb1ac301055e65d420879ec8 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-04 | 186 | 122 | 5 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 186 | 122 | 5 | 064b6047215597465bb51a8a1547ef5a226552f9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 186 | 122 | 5 | a1ab273b01971d6a892912560d387685dd657179 | |
| Drug | Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.13e-05 | 197 | 122 | 8 | 7217_UP | |
| Drug | Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.17e-05 | 198 | 122 | 8 | 2305_DN | |
| Drug | Levonordefrin [829-74-3]; Down 200; 21.8uM; MCF7; HT_HG-U133A | 1.17e-05 | 198 | 122 | 8 | 3450_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.22e-05 | 199 | 122 | 8 | 7366_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 1.22e-05 | 199 | 122 | 8 | 1648_DN | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.26e-05 | 200 | 122 | 8 | 2652_DN | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 5.55e-05 | 181 | 122 | 7 | 1236_UP | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; HL60; HT_HG-U133A | 8.04e-05 | 192 | 122 | 7 | 1286_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; PC3; HG-U133A | 8.31e-05 | 193 | 122 | 7 | 1961_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 8.31e-05 | 193 | 122 | 7 | 5764_DN | |
| Drug | Ajmaline [4360-12-7]; Down 200; 12.2uM; HL60; HG-U133A | 8.31e-05 | 193 | 122 | 7 | 1749_DN | |
| Drug | Dirithromycin [62013-04-1]; Down 200; 4.8uM; HL60; HG-U133A | 8.58e-05 | 194 | 122 | 7 | 1712_DN | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 8.58e-05 | 194 | 122 | 7 | 7538_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 8.58e-05 | 194 | 122 | 7 | 3604_DN | |
| Drug | monastrol; Up 200; 100uM; MCF7; HG-U133A | 8.86e-05 | 195 | 122 | 7 | 596_UP | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 8.86e-05 | 195 | 122 | 7 | 3358_DN | |
| Drug | Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 9.15e-05 | 196 | 122 | 7 | 2856_DN | |
| Drug | Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 9.15e-05 | 196 | 122 | 7 | 5007_DN | |
| Drug | Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 9.15e-05 | 196 | 122 | 7 | 1536_UP | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 6229_DN | |
| Drug | FK-506; Up 200; 1uM; MCF7; HG-U133A | 9.44e-05 | 197 | 122 | 7 | 284_UP | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 7344_UP | |
| Drug | (+/-)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 9.44e-05 | 197 | 122 | 7 | 161_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 1181_DN | |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Down 200; 6.2uM; HL60; HG-U133A | 9.75e-05 | 198 | 122 | 7 | 1721_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HG-U133A | 9.75e-05 | 198 | 122 | 7 | 347_DN | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; HL60; HG-U133A | 9.75e-05 | 198 | 122 | 7 | 1625_DN | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 3381_DN | |
| Drug | Metolazone [17560-51-9]; Up 200; 11uM; PC3; HG-U133A | 1.01e-04 | 199 | 122 | 7 | 1932_UP | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 7029_UP | |
| Drug | Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 6092_DN | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 3430_DN | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 1.04e-04 | 200 | 122 | 7 | 6992_DN | |
| Drug | Pergolide mesylate [66104-23-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.04e-04 | 200 | 122 | 7 | 7031_UP | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.04e-04 | 200 | 122 | 7 | 4959_DN | |
| Disease | basophil count, eosinophil count | 6.34e-06 | 241 | 119 | 8 | EFO_0004842, EFO_0005090 | |
| Disease | vascular endothelial growth factor measurement | 7.85e-05 | 56 | 119 | 4 | EFO_0004762 | |
| Disease | Hypertrophic Cardiomyopathy | 8.42e-05 | 57 | 119 | 4 | C0007194 | |
| Disease | eosinophil count | ELOB ZFAT CHERP BACH2 BEND3 BRD3 SEC31A SAMD15 CISH PAK2 RORA CACNA1H RERE CLEC16A TNXB CCDC9 TP53 | 9.97e-05 | 1488 | 119 | 17 | EFO_0004842 |
| Disease | colorectal cancer (is_implicated_in) | 1.34e-04 | 121 | 119 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | chordin-like protein 1 measurement | 1.60e-04 | 5 | 119 | 2 | EFO_0020257 | |
| Disease | Bilateral Wilms Tumor | 2.16e-04 | 29 | 119 | 3 | C2930471 | |
| Disease | lymphocyte count | ZFAT BACH2 BEND3 BRD3 CASZ1 ZNF710 GTF2IRD2B SSPN PTPN12 SEPTIN3 CDK13 GTF2IRD2 PAK2 RERE CDC5L CLEC16A | 2.68e-04 | 1464 | 119 | 16 | EFO_0004587 |
| Disease | seasonal allergic rhinitis | 2.91e-04 | 32 | 119 | 3 | EFO_0003956 | |
| Disease | Nephroblastoma | 4.14e-04 | 36 | 119 | 3 | C0027708 | |
| Disease | Glucocorticoid use measurement | 5.26e-04 | 39 | 119 | 3 | EFO_0009942 | |
| Disease | Colorectal Carcinoma | UNC13B MAP1B RBM10 OBSCN ARAP3 PKNOX1 GNAS SPAG17 EDRF1 TP53 | 5.66e-04 | 702 | 119 | 10 | C0009402 |
| Disease | Liver Diseases, Parasitic | 5.70e-04 | 9 | 119 | 2 | C0023897 | |
| Disease | Inhalant adrenergic use measurement | 6.28e-04 | 96 | 119 | 4 | EFO_0009941 | |
| Disease | Adrenal Gland Neoplasms | 8.66e-04 | 11 | 119 | 2 | C0001624 | |
| Disease | Adrenal Cancer | 8.66e-04 | 11 | 119 | 2 | C0750887 | |
| Disease | adult onset asthma | 1.35e-03 | 118 | 119 | 4 | EFO_1002011 | |
| Disease | diffuse idiopathic skeletal hyperostosis | 1.64e-03 | 15 | 119 | 2 | EFO_0007236 | |
| Disease | osteosarcoma (is_implicated_in) | 1.87e-03 | 16 | 119 | 2 | DOID:3347 (is_implicated_in) | |
| Disease | testosterone measurement | CAMP ESRRG LIPE PIN4 RTL9 RORA MYOCD YY1AP1 MYO15A TP53 TNS3 ARAP1 IGSF23 | 1.93e-03 | 1275 | 119 | 13 | EFO_0004908 |
| Disease | allergic rhinitis | 2.10e-03 | 133 | 119 | 4 | EFO_0005854 | |
| Disease | Alzheimer disease, brain volume measurement | 2.11e-03 | 17 | 119 | 2 | EFO_0006930, MONDO_0004975 | |
| Disease | neutrophil percentage of granulocytes | 2.36e-03 | 228 | 119 | 5 | EFO_0007994 | |
| Disease | eosinophil percentage of granulocytes | 2.64e-03 | 234 | 119 | 5 | EFO_0007996 | |
| Disease | serum albumin measurement | 2.81e-03 | 592 | 119 | 8 | EFO_0004535 | |
| Disease | respiratory system disease | 2.87e-03 | 145 | 119 | 4 | EFO_0000684 | |
| Disease | asthma, age at onset | 2.88e-03 | 70 | 119 | 3 | EFO_0004847, MONDO_0004979 | |
| Disease | alopecia | 2.99e-03 | 241 | 119 | 5 | MONDO_0004907 | |
| Disease | eosinophil percentage of leukocytes | 3.30e-03 | 746 | 119 | 9 | EFO_0007991 | |
| Disease | JT interval | 3.38e-03 | 248 | 119 | 5 | EFO_0007885 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 3.63e-03 | 76 | 119 | 3 | EFO_0003761, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | aspartate aminotransferase measurement | OBSCN BRD3 PRAG1 SEPTIN3 RORA MYO15A CLEC16A PRRC2A TP53 MYBPC3 | 3.66e-03 | 904 | 119 | 10 | EFO_0004736 |
| Disease | Paroxysmal atrial fibrillation | 3.73e-03 | 156 | 119 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 3.73e-03 | 156 | 119 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.73e-03 | 156 | 119 | 4 | C2585653 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KDPPSMATEAPPCVT | 271 | Q6UXB8 | |
| APTEAPDMAKVAPKP | 391 | Q9UPW8 | |
| EMEEPPPPDSSPTDI | 116 | Q8WVB6 | |
| DVEMDRKQPSPAPTP | 306 | Q9BYV9 | |
| EAPALPAPAAPMVSK | 421 | Q15059 | |
| DTDPMVNPPDSPETE | 406 | O75143 | |
| NPETKPARPDPIDMD | 131 | Q99459 | |
| LDPKSDSAMEPSPSP | 71 | Q8WWN8 | |
| PSVTPAAADPLMTPE | 376 | Q9NP70 | |
| FPASAAETKPPMAPS | 1071 | Q86V15 | |
| TPALPMPKEDAPSDP | 181 | Q9NSE2 | |
| MPKEDAPSDPALPAP | 186 | Q9NSE2 | |
| AETFPKLVPPPSAMA | 941 | Q5TGY3 | |
| AQKEMSPSPPAAQDP | 981 | Q9Y4F5 | |
| PVSEPPADQVASDMP | 1111 | Q6W2J9 | |
| PMDPTESPAAPEAAL | 31 | Q8N884 | |
| EFLRDVEPSKMPPPD | 996 | Q14004 | |
| MSHPPPAAREDKSPS | 111 | P54725 | |
| MDLPKLASDDRPSPP | 711 | P98175 | |
| SAAEILPAVPMEPKP | 386 | O60393 | |
| PEPPEAALSPMSIDS | 1001 | Q15334 | |
| VSPTEMVAKFQPPPE | 231 | Q5T5X7 | |
| KAMIPPTPLPTNDVD | 361 | Q06481 | |
| MSDGLDNEEKPPAPP | 1 | O75914 | |
| SVSPMDEPVPDSESP | 1376 | P46821 | |
| VPAPVKDEGPMVSAP | 621 | Q96JE9 | |
| TPAEPEVGPAAPAMA | 416 | Q14244 | |
| MADESETAVKPPAPP | 1 | P30419 | |
| MENKEAGTPPPIPSR | 1 | Q6PXP3 | |
| VPSPTLQPEDPAADM | 971 | Q9UKN7 | |
| PAPFEMPSSVSEDPS | 246 | Q3B7T1 | |
| FSPMPSEEKAASPPR | 171 | Q9NQW6 | |
| AEPPDPLPDKMRQSV | 1031 | Q9H6A9 | |
| LPVSGMDKPVFTDPP | 101 | Q9Y237 | |
| PDMPASQPIDIPDAK | 46 | Q9HBH9 | |
| PPAATSDPPAEDMLV | 711 | Q765P7 | |
| SPPFEKESEPESPMD | 291 | Q86W56 | |
| EEPSPPEDKMFFLDP | 361 | O94806 | |
| FMDEDPPKPPKVEVS | 546 | Q9UMN6 | |
| SPVPEMPTLPAEGSD | 221 | Q6ZVL6 | |
| MEEPQSDPSVEPPLS | 1 | P04637 | |
| SPVMPPPEEAAAVSA | 81 | Q86UU5 | |
| PDQKAEKSPPPMDSA | 271 | Q8IZQ8 | |
| SAQPEPPSPMAEEEL | 7331 | Q5VST9 | |
| MSDNGELEDKPPAPP | 1 | Q13177 | |
| ELEDKPPAPPVRMSS | 6 | Q13177 | |
| PTEAEPMEPDPTLSL | 136 | A1L1A6 | |
| MAAPPEPGEPEERKS | 1 | Q5RI15 | |
| QMEAEVKATPPPPAP | 346 | Q8IWX8 | |
| PDDSKPPIQMPGSSE | 376 | Q8IWX8 | |
| PPELPDVMKPQDSGS | 96 | Q15370 | |
| SPETSPKETPMQPPE | 386 | Q9Y3X0 | |
| QPASEKEPEMPGPRE | 16 | P35659 | |
| PEKIYAMPDPTVPDS | 246 | P62508 | |
| AMPDPTVPDSDIKAL | 251 | P62508 | |
| VMAPDVPATPVAPTE | 366 | Q5T0F9 | |
| APDPAPDSADEVMPE | 891 | Q9BTC0 | |
| LDPRPTMDGDPDTPK | 61 | P49913 | |
| MASDLDFSPPEVPEP | 1 | Q9NQG1 | |
| DPSEPSPADQAPMVL | 121 | Q8NA82 | |
| EKAEMVCAPSPAPAP | 16 | P12980 | |
| DTPPDTPPAMKNATS | 46 | Q3KQU3 | |
| TPTECPSMLEDPKLP | 6276 | Q8NDH2 | |
| APEEEGNPPESMKPA | 61 | O60269 | |
| PMEDSTPLVPSEEPN | 266 | Q86UP8 | |
| PMEDSTPLVPSEEPN | 266 | Q6EKJ0 | |
| KMSPPCISVEPPAED | 2186 | O95180 | |
| LESAMETDPDPVPPT | 151 | Q9P1V8 | |
| EEMPEKPVASPLGPA | 81 | Q5FWE3 | |
| PPEAFEMPLTADPTL | 571 | Q05469 | |
| DAPSSPVAALIPEMP | 301 | Q9HB75 | |
| PFPEPMDTQEAPTAE | 91 | Q9BTL4 | |
| PEDPFSSAPMTKPVT | 341 | P49757 | |
| IVPASPTDPCVEMDP | 691 | Q9H195 | |
| PPAFAVTPAAAMEEP | 11 | Q9Y6R4 | |
| MAEPLPPDAPAVSSE | 311 | A7E2F4 | |
| MAITAGSEEPDPPPE | 51 | Q9NZL4 | |
| LPKPAPDAEAMSPAL | 336 | Q8NET4 | |
| PNDKDPVVVPFPTMT | 306 | Q6PI48 | |
| SVEESPALEAPPMDK | 336 | A4FU49 | |
| SPPPVESQTPMDVDK | 41 | P55347 | |
| MAEEPQTPAENAPKP | 51 | Q96NT1 | |
| MATPTQTPTKAPEEP | 1 | P58549 | |
| PPPEEAMPFEAEQPS | 96 | Q5JWF2 | |
| DKSPDPNPIMTDTPI | 1176 | Q92859 | |
| MVSSIEPEKQDSPPP | 321 | Q05209 | |
| EDDKGMRSETPPVPP | 816 | P48634 | |
| PPAADAAGPDDMEPK | 16 | Q14714 | |
| ETPLMSEPTASVPPE | 216 | Q53GG5 | |
| PPPFMFKPVKEEDDG | 551 | Q9P2R6 | |
| SEKPPEQTPETAMPE | 1711 | Q9ULL5 | |
| EQTPETAMPEPPAPE | 1716 | Q9ULL5 | |
| LPPFPSPADVKETMT | 806 | Q68CZ2 | |
| KPVLEAMPTSEAPQP | 381 | Q6Q759 | |
| APARVMTKKEEPPPS | 241 | Q96P48 | |
| EVDSVAMAPAAPKIP | 21 | Q8N1N0 | |
| AQSPADAPMSPELPK | 931 | Q2KHT3 | |
| PNPEEAETESESMPP | 41 | Q14028 | |
| AEEPMATEPAPAGAP | 1276 | O75153 | |
| ELTKPPPLMAAEPTA | 451 | Q9ULP9 | |
| RKEPEAPGEMPAPAV | 546 | Q9P243 | |
| IPMDNKEVPGEAPAP | 41 | Q7L3S4 | |
| CSPAPSRKPEAMDEP | 3136 | Q8N2C7 | |
| LDEEVMALSPPSPPT | 336 | Q9C0A1 | |
| PEPPPSYDEAVKMAK | 151 | Q8NDY8 | |
| MESAPAAPDPAASEP | 1 | P35398 | |
| PVPPDSALESPFEEM | 6 | Q9UF11 | |
| DAAMSELVPEPRPKP | 11 | Q9UH03 | |
| SPTEPSMEAPEPAEE | 2081 | P22105 | |
| EEMAPASTEPPTPEP | 2286 | P22105 | |
| LSDPEAPSMESPEPV | 226 | Q8N1W2 | |
| APSMESPEPVKPEQG | 231 | Q8N1W2 | |
| PKEMKEDATTHPPPD | 331 | O14795 | |
| MSPGDCPPETTETPK | 331 | P13994 | |
| VADMKESLPPAAEPS | 306 | Q9NWT1 | |
| SMLSSPDAPKDPVPA | 1061 | Q86YV5 | |
| ESFESPAALPAMPPE | 521 | Q9H869 | |
| PELSPSVMPEAPLES | 11 | Q5T4F4 | |
| PVEAMAPPVEAGAAP | 206 | Q9BXU3 | |
| DFDFSPMSDKNPEPP | 376 | Q8N3G9 | |
| APSPLPKMADVSAEE | 96 | Q9BSL1 | |
| SMKPTPEEEPCNIFP | 661 | Q6ZMP0 | |
| ATPMTPGAKTQPPED | 156 | O94979 | |
| SPAKPAAPEDPQMPA | 26 | A0A1B0GWB2 | |
| SSPEPAPPSEAMDAD | 336 | Q96QC0 | |
| MAEESRKPSAPSPPD | 1 | Q15776 | |
| PMELRLDSPSAPDKP | 3061 | Q5THJ4 | |
| APDKPVVLPAIMPGD | 3071 | Q5THJ4 | |
| DQPAMSPEDKSPITP | 681 | Q14003 | |
| EAEKAEPMLAPAPAP | 96 | Q14896 | |
| KMEPSSFQPLPETEP | 146 | P28698 |